Inolex has announced the appointment of Kevin Gallagher as a non-executive member of its Board of Directors.
Kevin is a world-renowned executive in the cosmetic ingredient field, having recently stepped-down from a position at Croda, Inc.
Prior to retirement from Croda, Kevin was President, Croda North America (since 1999) and ultimately became the first President, Global Personal Care and Actives, when the group was reorganised in 2014.
A chemist by training, his nearly four-decade career has included successful roles in applications, research & development, sales, marketing and general management. During his time at Croda he co-invented seven patents and also was on the Executive Committee.
“We are delighted to have Kevin join our Board,” notes David Plimpton, President & CEO of Inolex. “He has been a visionary leader in the field of personal care ingredients, and we look forward to his guidance as we continue to serve our global clients with high value, innovative solutions. Kevin will bring exceptional industry insight and creativity during this important period of growth”
Inolex recently expanded operations in France with its 2015 acquisition of natural ingredients supplier IES LABO, and has expanded its Asian presence with a new innovation centre in Guangzhou, China.
